Postmastectomy radiotherapy appeared to increase the risks for minor complications and reoperations after immediate breast reconstruction.

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

As cancer progression has been linked with high glucose, adiposity, insulin resistance, and systemic inflammation, investigators studied several glucose-lowering drugs in relationship to cancer ...

Investigators examined the epidemiology of acral lentiginous melanoma in Black and White patients to establish if delayed diagnosis contributes to outcome disparities.

Significant differences seen in HNR and fundamental frequency between benign lesions and both healthy controls and laryngeal cancer.

Researchers sought to determine whether it would be feasible to administer treatment with HD-MTX for pediatric patients with advanced MB-NHL in Malawi.

To our knowledge, CONTACT-02 is the first phase 3 study of a tyrosine kinase inhibitor-immune checkpoint inhibitor combination to show a significant improvement in progression-free survival in ...

The Food and Drug Administration (FDA) has granted accelerated approval to Datroway ® (datopotamab deruxtecan-dlnk) for adults with locally advanced or metastatic epidermal growth factor receptor ...

Most deprived and/or non-Hispanic Black-concentrated areas had significantly higher advanced-to-localized IRRs for breast, cervical cancer.

A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, doctors, or other sources.

Daratumumab plus KRd “should be a new standard of care for newly diagnosed patients with multiple myeloma,” said C. Ola Landgren, MD, PhD.

Early surgical consultation in a multidisciplinary approach should be encouraged for patients with metastatic melanoma to optimize outcomes,” the researchers wrote.